Queena Yakun Zhao

Queena Yakun Zhao

Auto-generated profile, based on publicly available information

Queena Yakun Zhao

Department of Pediatrics, University of Michigan, Ann Arbor, MI

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2021 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
YZYakun Zhao
Yakun Zhao
AWAngela C. Weyand
Angela C. Weyand
JSJordan A. Shavit
Jordan A. Shavit

31 January 2025 in Blood Advances
Verified
Journal Article
Open access
CKChia-Jui Ku
Chia-Jui Ku
XYXinge Yu
Xinge Yu
QZQueena Y. Zhao
Queena Y. Zhao
SGSteven J. Grzegorski
Steven J. Grzegorski
JDJeffrey G. Daniel
Jeffrey G. Daniel
JSJordan A. Shavit
Jordan A. Shavit
Venous thrombosis is a leading cause of morbidity/mortality and associated with deficiencies of the anticoagulant protein C (PC; PROC) and its cofactor, protein S (PS; PROS1). Heterozygous mutations increase the risk of adult-onset thrombosis, whereas homozygous mutations result in pre/neonatal lethal thrombosis. Phenotypes of patients with PC and PS deficiency are generally considered clinically indistinguishable. Here, we generate proc (zebrafish PROC ortholog) and pros1 knockouts through genome editing in zebrafish and uncover partially discordant phenotypes. proc−/− mutants exhibited ∼70% lethality at 1 year of age, whereas pros1−/− survival was unaffected. Induced venous endothelial injury in both mutants revealed reduced occlusive thrombus formation. This is consistent with the consumptive coagulopathy of zebrafish antithrombin 3 knockouts, which also results in spontaneous venous thrombosis. However, proc and pros1 mutants revealed a discrepancy. Although both mutants demonstrated spontaneous thrombosis, proc−/− was localized to the cardiac and venous systems, whereas pros1−/− was intracardiac. Aside from coagulation, PC has been shown to have PS-independent roles in inflammation. proc mutants displayed altered inflammatory markers and defects in neutrophil migration independent of pros1. Transcriptomic analysis and gene knockdown identified novel proc genetic interactions with adgrf7, a G protein-coupled receptor (GPCR) not previously known to be involved in coagulation. In summary, our data reveal differences between PC- and PS-deficient thrombosis, with cardiovascular tissue–specific phenotypes and survival differences, suggesting the possibility of underlying clinical differences in affected patients. This model of complete proc−/− deficiency in an accessible organism will facilitate further in vivo study of these distinctions, as well as PS-dependent and -independent functions of PC.

25 September 2025 in Blood Advances
Verified
Journal Article
Open access
BWBrooke N. Wolford
Brooke N. Wolford
QZQueena Yakun Zhao
Queena Yakun Zhao
KWKuan-Han H. Wu
Kuan-Han H. Wu
XYXinge Yu
Xinge Yu
CRCatherine E. Richter
Catherine E. Richter
ISIda Surakka
Ida Surakka
Venous thromboembolisms (VTEs) are a leading cause of morbidity and mortality. Although many genetic risk factors have been identified, a substantial portion of the heritability remains unexplained. In this study, we employed a genome-wide association study (GWAS) for VTE across 9 international cohorts of the Global Biobank Meta-Analysis Initiative to address this question, along with in vivo functional validation. In this multipopulation GWAS (VTE cases, 27 987; controls, 1 035 290), 38 genome-wide significant loci were identified, 4 of which were potentially novel. For each autosomal locus, we performed gene prioritization using 7 independent, yet converging, lines of evidence. Through prioritization, we identified genes associated with VTE through GWAS and/or functional studies (eg, F5, F11, VWF, STAB2, PLCG2, TC2N), functionally validated those that did not have evidence other than GWAS (TC2N, TSPAN15), and discovered 1 not previously associated with coagulation (RASIP1). We evaluated the function of 6 prioritized genes with strong genetic evidence, including F7 as a positive control, using laser-mediated endothelial injury to induce thrombosis in zebrafish after CRISPR/Cas9 knockdown. From this assay, we have supportive evidence for the role of RASIP1 and TC2N in the modification of human VTE and suggestive evidence for STAB2 and TSPAN15. This study expands on the currently identified genomic architecture of VTE through biobank-based, multipopulation GWASs, in silico candidate gene predictions, and in vivo functional follow-up of candidate genes.